START was a noninferiority randomized controlled trial testing accelerated steroid tapering among adults with steroid-sensitive podocytopathies.

Trial findings support further evaluation of FANS ureteral access sheath for infectious stone removal in well-selected patients.

Researchers evaluated the long-term cardiovascular implications of isolated diastolic hypertension among young adults without preexisting disease.

The FDA has approved Degevma (denosumab-adet), a new biosimilar to Xgeva, to prevent skeletal-related events in patients with bone metastases.

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.

Trial investigators evaluated the prognostic and predictive ability of PAM50 molecular prostate cancer subtypes to guide salvage treatment.

Genetic testing was performed in patients with FSGS, classic MCD, and MCD with IgM deposition, with no pathogenic or likely pathogenic variants associated with monogenic SRNS identified. In children ...

Men with frailty have higher risk for cognitive impairment than men without frailty, but no association seen in women. (HealthDay News) — For men with nondialysis chronic kidney disease (CKD), frailty ...

Joint mediation combined was estimated to be 31.4 percent for all potential mediators. (HealthDay News) — The effects of semaglutide on major adverse cardiovascular events (MACE) is only partially due ...

Findings seen in adults aged 40 to 80 years with at least two cardiovascular risk factors. (HealthDay News) — For adults with an increased cardiovascular risk, elevated C-reactive protein (CRP) levels ...